C-(3-Chloro-5-trifluoromethyl-pyridin-2-yl)-methylamine; compound with acetic acid, 95.0%, 5g

(R)-tert-Butyl 1,4-oxazepan-6-ylcarbamate, 97%, 5g

4-Formylaminoantipyrine>98.0%(GC)250mg

2-Chloro-5-nitrobenzoic acid, 99.00%, 25g

6-Bromo-2,2-dimethyl-2,3-dihydro-1H-inden-1-one, 98%, 100mg

[2-(benzoylamino)-1,3-thiazol-4-yl]acetic acid, 95.0%, 2.5g

(S)-3-(1H-Indol-3-yl)-N-((1-(4-methoxyphenyl)cyclohexyl)methyl)-2-(3-(4-nitrophenyl)ureido)propanamide, 98%, 100mg

6-methoxy-2-(5-methyl-2-furanyl)-N-(1-methyl-4-piperidinyl)-7-[3-(1-pyrrolidinyl)propoxy]-4-quinolinamine, 50mg

(1R,2R,5S)-3-[(tert-butoxy)carbonyl]-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 95.0%, 100mg

5-Chloro-2-methoxynicotinic acid, 95.0%, 5g

Methyl 2-Methyl-4-nitrobenzoate, 97.0%, 100g

1-(4-Bromobenzenesulfonyl)piperidine-3-carboxylic acid, 95%, 100mg

3-Ethynyl-5-fluoropyridin-2-amine, 95.0%, 5g